
DSM Firmenich Investor Relations Material
Latest events

Q1 2025
DSM Firmenich
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from DSM Firmenich AG
Access all reports
DSM-Firmenich engages in nutrition, health, and sustainable living businesses in Europe, North America, Latin America, China, and internationally. The company’s Human Nutrition & Health segment offers nutritional and pharmaceutical ingredients for infant, medical, sports, clinical, and weight management markets; and premixes for food and beverage manufacturers as well as supplements. Its Performance Materials segment provides resins and compounds to food packaging and medical device industries; engineering plastics for automotive applications; speciality engineering plastics for electronics; resins for architectural applications; and additives and functional solutions for paints, coatings, construction chemicals, adhesives, paper production chemicals, oil field chemicals, supplies inks to the printing industry.
Key slides for DSM Firmenich AG


H1 2024
DSM Firmenich AG


Q1 2025
DSM Firmenich AG
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
DSFIR
Country
🇳🇱 Netherlands